Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.

Por Kinkel, R P, Rudick, R A, Ransohoff, R M
Publicado em 1997

T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking

Por Kivisäkk, P, Trebst, C, Liu, Z, Tucky, B H, Sørensen, T L, Rudick, R A, Mack, M, Ransohoff, R M
Publicado em 2002

Using an Automated Recruitment Process to Generate an Unbiased Study Sample of Multiple Sclerosis Patients

Por Miller, Deborah M., Fox, R., Atreja, A., Moore, S., Lee, J.-C., Fu, A.Z., Jain, A., Saupe, W., Chakraborty, S., Stadtler, M., Rudick, R.A.
Publicado em 2010

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

Por Rudick, R A., Pace, A, Rani, M R.S., Hyde, R, Panzara, M, Appachi, S, Shrock, J, Maurer, S L., Calabresi, P A., Confavreux, C, Galetta, S L., Lublin, F D., Radue, E -W., Ransohoff, R M.
Publicado em 2009